Literature DB >> 8775771

A morphologist's approach to the vagina--age-related changes and estrogen sensitivity.

J G Forsberg1.   

Abstract

This paper reviews basic facts on vagina histology and ultrastructure with respect to passage of different substances and drugs through the epithelium. Particular interest is devoted to the action mechanism of topically-applied vaginal estrogen, its binding to receptors in different vaginal cell types, and possible local metabolic routes. Differences in estrogen sensitivity between uterus and vagina are discussed as well as the background for the high vaginal sensitivity.

Mesh:

Substances:

Year:  1995        PMID: 8775771     DOI: 10.1016/0378-5122(95)00957-4

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  15 in total

1.  Management of urinary incontinence.

Authors:  George A Demaagd; Timothy C Davenport
Journal:  P T       Date:  2012-06

2.  Prevalence and correlates of vaginal estrogenization in postmenopausal women in the United States.

Authors:  Stacy Tessler Lindau; Annie Dude; Natalia Gavrilova; Joscelyn N Hoffmann; L Philip Schumm; Martha K McClintock
Journal:  Menopause       Date:  2017-05       Impact factor: 2.953

3.  Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women.

Authors:  Tomas L Griebling; Zhaohui Liao; Peter G Smith
Journal:  Menopause       Date:  2012-06       Impact factor: 2.953

4.  Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus.

Authors:  Laura M Ensign; Benjamin C Tang; Ying-Ying Wang; Terence A Tse; Timothy Hoen; Richard Cone; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

5.  Bone morphogenetic protein 4 mediates estrogen-regulated sensory axon plasticity in the adult female reproductive tract.

Authors:  Aritra Bhattacherjee; M A Karim Rumi; Hinrich Staecker; Peter G Smith
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

6.  Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid.

Authors:  Colin MacNeill; Todd M Umstead; David S Phelps; Zhenwu Lin; Joanna Floros; Debra A Shearer; Judith Weisz
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

7.  [Urinary incontinence in the elderly: what can and should be done?].

Authors:  B Amend; S Kruck; J Bedke; R Ritter; L Arenas da Silva; C Chapple; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

8.  Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Authors:  Laura M Ensign; Timothy E Hoen; Katharina Maisel; Richard A Cone; Justin S Hanes
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

9.  Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Authors:  Irina A Zalenskaya; Neelima Chandra; Nazita Yousefieh; Xi Fang; Oluwatosin E Adedipe; Suzanne S Jackson; Sharon M Anderson; Christine K Mauck; Jill L Schwartz; Andrea R Thurman; Gustavo F Doncel
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

10.  Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat.

Authors:  Noel N Kim; Miljan Stankovic; Abdullah Armagan; Tulay T Cushman; Irwin Goldstein; Abdulmaged M Traish
Journal:  BMC Womens Health       Date:  2006-09-13       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.